The risk or severity of adverse effects can be increased when zopiclone is combined with ondansetron.


The risk or severity of adverse effects can be increased when nortriptyline is combined with periciazine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Normethadone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tolmetin is combined with oxaprozin.


The risk or severity of adverse effects can be increased when felodipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Nintedanib.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with sevoflurane.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with indomethacin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when phenytoin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when meprobamate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Paliperidone is combined with glutethimide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when epinastine is combined with Apixaban.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with prazepam.


The risk or severity of adverse effects can be increased when pimozide is combined with cetirizine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with thiothixene.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when trandolapril is combined with resveratrol.


The risk or severity of adverse effects can be increased when enflurane is combined with clonazepam.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nimodipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when buspirone is combined with glutethimide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when cocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with cetirizine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with streptozocin.


The risk or severity of adverse effects can be increased when ketorolac is combined with nimesulide.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with protriptyline.


The risk or severity of adverse effects can be increased when thiopental is combined with sertraline.


The risk or severity of adverse effects can be increased when Eprosartan is combined with carprofen.


The risk or severity of adverse effects can be increased when HEROIN is combined with Phenelzine.


The risk or severity of adverse effects can be increased when tiagabine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when resveratrol is combined with fenbufen.


The risk or severity of adverse effects can be increased when imipramine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when desoximetasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with tibolone.


The risk or severity of adverse effects can be increased when perphenazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when pancuronium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when estazolam is combined with tetracaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with haloperidol.


The risk or severity of adverse effects can be increased when nimesulide is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when cabergoline is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when nimesulide is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Perospirone is combined with tizanidine.


The risk or severity of adverse effects can be increased when levorphanol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when quazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when morniflumate is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when promazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with codeine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nifedipine.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with lovastatin.


The risk or severity of adverse effects can be increased when diltiazem is combined with quetiapine.


The risk or severity of adverse effects can be increased when morniflumate is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when morniflumate is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when docetaxel is combined with Niraparib.


The risk or severity of adverse effects can be increased when ethanol is combined with Rufinamide.


The risk or severity of adverse effects can be increased when Asenapine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Asenapine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Asenapine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when methysergide is combined with Quinine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when ibudilast is combined with Apixaban.


The risk or severity of adverse effects can be increased when Pipamperone is combined with indapamide.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with medrysone.


The risk or severity of adverse effects can be increased when cabergoline is combined with Flupentixol.


The risk or severity of adverse effects can be increased when cabergoline is combined with rapamycin.


The risk or severity of adverse effects can be increased when morphine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Naftifine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxycodone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when oxycodone is combined with clidinium.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when ketorolac is combined with Mivacurium.


The risk or severity of adverse effects can be increased when furosemide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when acemetacin is combined with haloperidol.


The risk or severity of adverse effects can be increased when Melatonin is combined with benzocaine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nimodipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Lofexidine.


The risk or severity of adverse effects can be increased when haloperidol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when floctafenine is combined with Apremilast.


The risk or severity of adverse effects can be increased when meperidine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when protriptyline is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when xylometazoline is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when tetracaine is combined with clidinium.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Butethal.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when enalapril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when suprofen is combined with azelastine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with HEROIN.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with tiapride.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with galanthamine.


The risk or severity of adverse effects can be increased when bromazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with furosemide.


The risk or severity of adverse effects can be increased when bromazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with tizanidine.


The risk or severity of adverse effects can be increased when ketorolac is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when prilocaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when trandolapril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when clonidine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when bepridil is combined with dipyridamole.


The risk or severity of adverse effects can be increased when lorazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when lorazepam is combined with amobarbital.


The risk or severity of adverse effects can be increased when Mometasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when lorazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when lorazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when fosinopril is combined with metolazone.


The risk or severity of adverse effects can be increased when reserpine is combined with nimodipine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Melatonin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with clonazepam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with promethazine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when methazolamide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with tolmetin.


The risk or severity of adverse effects can be increased when reserpine is combined with digoxin.


The risk or severity of adverse effects can be increased when salicylamide is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when terconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when methysergide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Naftifine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Conivaptan is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ketamine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with nadolol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with RANOLAZINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when olanzapine is combined with Etomidate.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with perphenazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when olanzapine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when olanzapine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with triprolidine.


The risk or severity of adverse effects can be increased when buspirone is combined with lidocaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with methylphenidate.


The risk or severity of adverse effects can be increased when metoprolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when dantrolene is combined with Iloperidone.


The risk or severity of adverse effects can be increased when triazolam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Micafungin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Pipamperone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with benazepril.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Olsalazine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with promethazine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with clonazepam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with bumetanide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Echothiophate.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with norfloxacin.


The risk or severity of adverse effects can be increased when clonazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with halothane.


The risk or severity of adverse effects can be increased when trandolapril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Icatibant is combined with prednisone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with modafinil.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with butalbital.


The risk or severity of adverse effects can be increased when nicotinamide is combined with simvastatin.


The risk or severity of adverse effects can be increased when diflorasone is combined with memantine.


The risk or severity of adverse effects can be increased when pravastatin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when clomipramine is combined with nimodipine.


The risk or severity of adverse effects can be increased when clomipramine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when trandolapril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with meclizine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when thioridazine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when losartan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with trimipramine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with nadolol.


The risk or severity of adverse effects can be increased when metoprolol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when metoprolol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when leflunomide is combined with resveratrol.


The risk or severity of adverse effects can be increased when levorphanol is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when irbesartan is combined with Nepafenac.


The risk or severity of adverse effects can be increased when lidocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with clidinium.


The risk or severity of adverse effects can be increased when tetracaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sulindac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when tetracaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when aspirin is combined with mesalamine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with busulfan.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with hydroxyurea.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with trimipramine.


The risk or severity of adverse effects can be increased when etizolam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with procarbazine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with HEROIN.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Clobetasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with flurazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with doxepin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with tolmetin.


The risk or severity of adverse effects can be increased when Clobetasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when furosemide is combined with deslanoside.


The risk or severity of adverse effects can be increased when ketamine is combined with desipramine.


The risk or severity of adverse effects can be increased when morphine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ketamine is combined with thiamylal.


The risk or severity of adverse effects can be increased when ketamine is combined with halothane.


The risk or severity of adverse effects can be increased when felbamate is combined with levodopa.


The risk or severity of adverse effects can be increased when pramipexole is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with penbutolol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when acebutolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ketamine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when irbesartan is combined with fenbufen.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when mitoxantrone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when morphine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when ketamine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when clotrimazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with trazodone.


The risk or severity of adverse effects can be increased when Butethal is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Normethadone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when tretinoin is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Paliperidone.


The risk or severity of adverse effects can be increased when trimetrexate is combined with barnidipine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Telmisartan.


The risk or severity of adverse effects can be increased when tiapride is combined with nortriptyline.


The risk or severity of adverse effects can be increased when tiapride is combined with amoxapine.


The risk or severity of adverse effects can be increased when pramipexole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Asenapine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with triprolidine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Propacetamol.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with etodolac.


The risk or severity of adverse effects can be increased when pancuronium is combined with methadone.


The risk or severity of adverse effects can be increased when oxycodone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with brotizolam.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with metoclopramide.


The risk or severity of adverse effects can be increased when oxycodone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with cilazapril.


The risk or severity of adverse effects can be increased when oxycodone is combined with triazolam.


The risk or severity of adverse effects can be increased when isoflurane is combined with benzocaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when isoflurane is combined with vigabatrin.


The risk or severity of adverse effects can be increased when metoclopramide is combined with TRIMETAZIDINE.


The risk or severity of adverse effects can be increased when propofol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Capsaicin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with losartan.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when METAXALONE is combined with dantrolene.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with eperisone.


The risk or severity of adverse effects can be increased when thioridazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with dorzolamide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when codeine is combined with meperidine.


The risk or severity of adverse effects can be increased when codeine is combined with loratadine.


The risk or severity of adverse effects can be increased when etodolac is combined with antipyrine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when quinapril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Remoxipride is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Alogliptin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Halazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when citalopram is combined with sumatriptan.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Benidipine.


The risk or severity of adverse effects can be increased when azelastine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when isoflurane is combined with tetracaine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when estazolam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when betaxolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with morphine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when methylene blue is combined with linezolid.


The risk or severity of adverse effects can be increased when protriptyline is combined with nortriptyline.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Sacubitril.


The risk or severity of adverse effects can be increased when phenylephrine is combined with metaraminol.


The risk or severity of adverse effects can be increased when alprazolam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when oxycodone is combined with doxepin.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with primidone.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with captopril.


The risk or severity of adverse effects can be increased when phentolamine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when oxycodone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with antipyrine.


The risk or severity of adverse effects can be increased when ipratropium is combined with pentazocine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Pramocaine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ipratropium is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when fenofibrate is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with amoxapine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with propantheline.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when quetiapine is combined with hydralazine.


The risk or severity of adverse effects can be increased when equilin is combined with rivastigmine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when phenobarbital is combined with proparacaine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Halazepam.


The risk or severity of adverse effects can be increased when trimetrexate is combined with felodipine.


The risk or severity of adverse effects can be increased when risperidone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Metixene is combined with pentazocine.


The risk or severity of adverse effects can be increased when lidocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Vapreotide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when celiprolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when halothane is combined with captopril.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with clonidine.


The risk or severity of adverse effects can be increased when selegiline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when betamethasone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with quetiapine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when equilin is combined with galanthamine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when equilin is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when isoflurane is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with clomipramine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with salicylamide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with butamben.


The risk or severity of adverse effects can be increased when prazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Tapentadol.


The risk or severity of adverse effects can be increased when cabergoline is combined with Lapatinib.


The risk or severity of adverse effects can be increased when fenbufen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Temsirolimus is combined with rescinnamine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with dantrolene.


The risk or severity of adverse effects can be increased when Aclidinium is combined with methadone.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with salicylic acid.


The risk or severity of adverse effects can be increased when baclofen is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when buprenorphine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when zopiclone is combined with estazolam.


The risk or severity of adverse effects can be increased when clidinium is combined with Retigabine.


The risk or severity of adverse effects can be increased when estazolam is combined with butamben.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with scopolamine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with reserpine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when felodipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when amobarbital is combined with nefazodone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with clidinium.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when loratadine is combined with trimipramine.


The risk or severity of adverse effects can be increased when alclometasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when spironolactone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with scopolamine.


The risk or severity of adverse effects can be increased when alclometasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when pergolide is combined with Lomitapide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with zolpidem.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with dyclonine.


The risk or severity of adverse effects can be increased when methylene blue is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when methylene blue is combined with Vilanterol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with methocarbamol.


The risk or severity of adverse effects can be increased when dibucaine is combined with loratadine.


The risk or severity of adverse effects can be increased when amobarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when timolol is combined with acebutolol.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with Emtricitabine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when prazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when bumetanide is combined with Amrubicin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when Eluxadoline is combined with Naloxegol.


The risk or severity of adverse effects can be increased when oxazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when timolol is combined with captopril.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when trimipramine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Salsalate is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when butabarbital is combined with pimozide.


The risk or severity of adverse effects can be increased when Salsalate is combined with fenbufen.


The risk or severity of adverse effects can be increased when amiodarone is combined with ILOPROST.


The risk or severity of adverse effects can be increased when thiopental is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with quinapril.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with cocaine.


The risk or severity of adverse effects can be increased when Trospium is combined with pirenzepine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when doxazosin is combined with nifedipine.


The risk or severity of adverse effects can be increased when prazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when zopiclone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when doxazosin is combined with papaverine.


The risk or severity of adverse effects can be increased when morniflumate is combined with chloroquine.


The risk or severity of adverse effects can be increased when indapamide is combined with felodipine.


The risk or severity of adverse effects can be increased when indapamide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with carvedilol.


The risk or severity of adverse effects can be increased when clozapine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ambroxol.


The risk or severity of adverse effects can be increased when indapamide is combined with irbesartan.


The risk or severity of adverse effects can be increased when alclofenac is combined with estrone.


The risk or severity of adverse effects can be increased when secobarbital is combined with Remoxipride.


The risk or severity of adverse effects can be increased when nisoldipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when secobarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when minoxidil is combined with methazolamide.


The risk or severity of adverse effects can be increased when codeine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rivaroxaban.


The risk or severity of adverse effects can be increased when Agomelatine is combined with butalbital.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when morphine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with nabumetone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with HEROIN.


The risk or severity of adverse effects can be increased when gabapentin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ketorolac.


The risk or severity of adverse effects can be increased when Tramadol is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when pergolide is combined with nicotinamide.


The risk or severity of adverse effects can be increased when Tramadol is combined with sevoflurane.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with tenoxicam.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with levodopa.


The risk or severity of adverse effects can be increased when Tramadol is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nimesulide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when trimipramine is combined with maprotiline.


The risk or severity of adverse effects can be increased when nicotinamide is combined with lovastatin.


The risk or severity of adverse effects can be increased when reserpine is combined with amobarbital.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with reserpine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when dyclonine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Arotinolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nicardipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with efavirenz.


The risk or severity of adverse effects can be increased when selegiline is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with clonazepam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with promethazine.


The risk or severity of adverse effects can be increased when codeine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when pergolide is combined with amprenavir.


The risk or severity of adverse effects can be increased when oxycodone is combined with Mersalyl.


The risk or severity of adverse effects can be increased when pergolide is combined with methazolamide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with olanzapine.


The risk or severity of adverse effects can be increased when linezolid is combined with olanzapine.


The risk or severity of adverse effects can be increased when chloroxine is combined with Amrinone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Normethadone.


The risk or severity of adverse effects can be increased when sulpiride is combined with clidinium.


The risk or severity of adverse effects can be increased when temazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with prednisone.


The risk or severity of adverse effects can be increased when Halazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with felodipine.


The risk or severity of adverse effects can be increased when midazolam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when reserpine is combined with Butethal.


The risk or severity of adverse effects can be increased when terazosin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when spiramycin is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Perospirone is combined with loratadine.


The risk or severity of adverse effects can be increased when bumetanide is combined with daunorubicin.


The risk or severity of adverse effects can be increased when alclometasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when indomethacin is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Perospirone is combined with imipramine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Perospirone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with fenoprofen.


The risk or severity of adverse effects can be increased when butabarbital is combined with Olopatadine.


The risk or severity of adverse effects can be increased when scopolamine is combined with topiramate.


The risk or severity of adverse effects can be increased when haloperidol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with promethazine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with clonazepam.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when barnidipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when biperiden is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with ethotoin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with promethazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when thioridazine is combined with nimodipine.


The risk or severity of adverse effects can be increased when propantheline is combined with Normethadone.


The risk or severity of adverse effects can be increased when thioridazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when isradipine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when amitriptyline is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with carisoprodol.


The risk or severity of adverse effects can be increased when tubocurarine is combined with topiramate.


The risk or severity of adverse effects can be increased when apomorphine is combined with felodipine.


The risk or severity of adverse effects can be increased when selegiline is combined with buspirone.


The risk or severity of adverse effects can be increased when selegiline is combined with oxycodone.


The risk or severity of adverse effects can be increased when dicyclomine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when lithium ion is combined with clidinium.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with clonazepam.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when pimozide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when nilvadipine is combined with papaverine.


The risk or severity of adverse effects can be increased when isoflurane is combined with fludiazepam.


The risk or severity of adverse effects can be increased when thiothixene is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when doxorubicin is combined with zidovudine.


The risk or severity of adverse effects can be increased when estazolam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Riociguat.


The risk or severity of adverse effects can be increased when olanzapine is combined with meprobamate.


The risk or severity of adverse effects can be increased when prazosin is combined with furosemide.


The risk or severity of adverse effects can be increased when PRIMAQUINE is combined with mefloquine.


The risk or severity of adverse effects can be increased when thiopental is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with cilostazol.


The risk or severity of adverse effects can be increased when Pregabalin is combined with fluvastatin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Triflusal is combined with diflunisal.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when ethionamide is combined with D-cycloserine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with budesonide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with formestane.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when niflumic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when ethotoin is combined with felbamate.


The risk or severity of adverse effects can be increased when oxprenolol is combined with clemastine.


The risk or severity of adverse effects can be increased when procyclidine is combined with biperiden.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with quetiapine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when reserpine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Pipamperone.


The risk or severity of adverse effects can be increased when reserpine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when methocarbamol is combined with duloxetine.


The risk or severity of adverse effects can be increased when indomethacin is combined with suprofen.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with celiprolol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with chloroquine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with BENZNIDAZOLE.


The risk or severity of adverse effects can be increased when thioridazine is combined with oxazepam.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with butamben.


The risk or severity of adverse effects can be increased when Nepafenac is combined with sulindac.


The risk or severity of adverse effects can be increased when Clofarabine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with aspirin.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with PHENPROCOUMON.


The risk or severity of adverse effects can be increased when Nabilone is combined with quinapril.


The risk or severity of adverse effects can be increased when Nabilone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Nabilone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when triamcinolone is combined with leflunomide.


The risk or severity of adverse effects can be increased when procarbazine is combined with periciazine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when mesalamine is combined with DEXKETOPROFEN.


The risk or severity of adverse effects can be increased when amoxapine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when mesalamine is combined with estrone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with budesonide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when isradipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when nitrendipine is combined with prazosin.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with quinapril.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with buspirone.


The risk or severity of adverse effects can be increased when methysergide is combined with testosterone.


The risk or severity of adverse effects can be increased when methysergide is combined with efavirenz.


The risk or severity of adverse effects can be increased when methysergide is combined with nicardipine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when zopiclone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Apremilast is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when prilocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Melatonin is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Benidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with irbesartan.


The risk or severity of adverse effects can be increased when barnidipine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when zaleplon is combined with butamben.


The risk or severity of adverse effects can be increased when quetiapine is combined with Articaine.


The risk or severity of adverse effects can be increased when flumethasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when lorazepam is combined with estazolam.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Metixene.


The risk or severity of adverse effects can be increased when nitrendipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when venlafaxine is combined with thiothixene.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Pramocaine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with butalbital.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with meclizine.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with Apixaban.


The risk or severity of adverse effects can be increased when bromocriptine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ritonavir.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with butamben.


The risk or severity of adverse effects can be increased when midazolam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Flupentixol is combined with phenytoin.


The risk or severity of adverse effects can be increased when enflurane is combined with HEROIN.


The risk or severity of adverse effects can be increased when zaleplon is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Capsaicin.


The risk or severity of adverse effects can be increased when amobarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Propacetamol.


The risk or severity of adverse effects can be increased when enflurane is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when barnidipine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when levorphanol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when methadone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when suprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when morphine is combined with papaverine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Halobetasol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when maprotiline is combined with vigabatrin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ethotoin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when perphenazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Naftifine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with enflurane.


The risk or severity of adverse effects can be increased when nicardipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with enoxacin.


The risk or severity of adverse effects can be increased when dexamethasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when oxazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with isoflurane.


The risk or severity of adverse effects can be increased when zotepine is combined with maprotiline.


The risk or severity of adverse effects can be increased when pentazocine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when irbesartan is combined with salicylamide.


The risk or severity of adverse effects can be increased when tetracaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Propiverine.


The risk or severity of adverse effects can be increased when tetracaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when oxazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with docetaxel.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with spironolactone.


The risk or severity of adverse effects can be increased when 5-Fluorouracil is combined with clozapine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when pentazocine is combined with moclobemide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with trimipramine.


The risk or severity of adverse effects can be increased when losartan is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when METAXALONE is combined with primidone.


The risk or severity of adverse effects can be increased when Voriconazole is combined with vincristine.


The risk or severity of adverse effects can be increased when losartan is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when losartan is combined with felodipine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when losartan is combined with irbesartan.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Etidocaine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when amphotericin b is combined with minoxidil.


The risk or severity of adverse effects can be increased when zaleplon is combined with baclofen.


The risk or severity of adverse effects can be increased when rasagiline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when gabapentin is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when sulindac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when methoxamine is combined with terbutaline.


The risk or severity of adverse effects can be increased when thiopental is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when imipramine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when dexamethasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when thiopental is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when imipramine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when butamben is combined with paroxetine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when probenecid is combined with Torasemide.


The risk or severity of adverse effects can be increased when papaverine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when papaverine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with amoxapine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Efonidipine is combined with thioridazine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when polythiazide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with tiapride.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when atenolol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when aspirin is combined with DEXKETOPROFEN.


The risk or severity of adverse effects can be increased when morphine is combined with tolazoline.


The risk or severity of adverse effects can be increased when morphine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Nabilone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Butethal.


The risk or severity of adverse effects can be increased when aspirin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with sotalol.


The risk or severity of adverse effects can be increased when labetalol is combined with losartan.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with lithium ion.


The risk or severity of adverse effects can be increased when amifostine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when thiothixene is combined with primidone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with equilin.


The risk or severity of adverse effects can be increased when Halazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with diflunisal.


The risk or severity of adverse effects can be increased when bepridil is combined with diltiazem.


The risk or severity of adverse effects can be increased when dopamine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when enalapril is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Eprosartan is combined with antipyrine.


The risk or severity of adverse effects can be increased when pancuronium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when cilnidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when protriptyline is combined with levodopa.


The risk or severity of adverse effects can be increased when benztropine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when rasagiline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when rasagiline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with estrone.


The risk or severity of adverse effects can be increased when Normethadone is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when nimodipine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Normethadone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when thiothixene is combined with methocarbamol.


The risk or severity of adverse effects can be increased when thiothixene is combined with methylphenidate.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with malathion.


The risk or severity of adverse effects can be increased when procaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when carmustine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with penbutolol.


The risk or severity of adverse effects can be increased when HEROIN is combined with butalbital.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with salicylic acid.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when butorphanol is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when ketamine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when zonisamide is combined with paroxetine.


The risk or severity of adverse effects can be increased when ketamine is combined with amisulpride.


The risk or severity of adverse effects can be increased when imipramine is combined with citalopram.


The risk or severity of adverse effects can be increased when imipramine is combined with Torasemide.


The risk or severity of adverse effects can be increased when methylphenidate is combined with amoxapine.


The risk or severity of adverse effects can be increased when Butethal is combined with scopolamine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with dyclonine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Paliperidone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when phenobarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when losartan is combined with resveratrol.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when hydromorphone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when tiagabine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with resveratrol.


The risk or severity of adverse effects can be increased when estazolam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when chloroxine is combined with Benidipine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with gabapentin.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when pargyline is combined with moclobemide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ifosfamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with fenbufen.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Articaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with triprolidine.


The risk or severity of adverse effects can be increased when acemetacin is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when methysergide is combined with SIMEPREVIR.


The risk or severity of adverse effects can be increased when methazolamide is combined with irbesartan.


The risk or severity of adverse effects can be increased when mesoridazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Olmesartan is combined with diflunisal.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Phenelzine.


The risk or severity of adverse effects can be increased when alprazolam is combined with promazine.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with fluvastatin.


The risk or severity of adverse effects can be increased when estazolam is combined with imipramine.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with oxycodone.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with rasagiline.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when proparacaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Eprosartan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when zotepine is combined with dantrolene.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sulindac is combined with niflumic acid.


The risk or severity of adverse effects can be increased when risperidone is combined with meclizine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when floctafenine is combined with indomethacin.


The risk or severity of adverse effects can be increased when amifostine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when clonidine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when chloroquine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when benazepril is combined with floctafenine.


The risk or severity of adverse effects can be increased when Bretylium is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when ketamine is combined with dyclonine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with lidocaine.


The risk or severity of adverse effects can be increased when temazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when prilocaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when prilocaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when lithium ion is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when sulfacytine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with loteprednol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with brotizolam.


The risk or severity of adverse effects can be increased when citric acid is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when spironolactone is combined with cilazapril.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when sulfaphenazole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ketamine.


The risk or severity of adverse effects can be increased when resveratrol is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with quetiapine.


The risk or severity of adverse effects can be increased when ganciclovir is combined with lamivudine.


The risk or severity of adverse effects can be increased when naratriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with topiramate.


The risk or severity of adverse effects can be increased when naratriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with Articaine.


The risk or severity of adverse effects can be increased when Nabilone is combined with nilvadipine.


The risk or severity of adverse effects can be increased when medrysone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when temazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when trimipramine is combined with periciazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when minoxidil is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with decamethonium.


The risk or severity of adverse effects can be increased when Etomidate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when suprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Olopatadine.


The risk or severity of adverse effects can be increased when flunarizine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when floctafenine is combined with salicylamide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with flunisolide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Propacetamol.


The risk or severity of adverse effects can be increased when amoxapine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Clofarabine.


The risk or severity of adverse effects can be increased when loxapine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when butalbital is combined with fluoxetine.


The risk or severity of adverse effects can be increased when butalbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when temazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when methylphenidate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when secobarbital is combined with nitrazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with amisulpride.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Normethadone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when sulindac is combined with paramethasone.


The risk or severity of adverse effects can be increased when bromazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with gabapentin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when nicotinamide is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when vigabatrin is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with trimipramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with procaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with lisinopril.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when triazolam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when pentazocine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Droxicam is combined with triamcinolone.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with lisinopril.


The risk or severity of adverse effects can be increased when lidocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when cimetidine is combined with phenytoin.


The risk or severity of adverse effects can be increased when losartan is combined with Spirapril.


The risk or severity of adverse effects can be increased when flurazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when losartan is combined with cilazapril.


The risk or severity of adverse effects can be increased when procarbazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when papaverine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Tramadol.


The risk or severity of adverse effects can be increased when clomipramine is combined with citalopram.


The risk or severity of adverse effects can be increased when clomipramine is combined with Torasemide.


The risk or severity of adverse effects can be increased when phenobarbital is combined with enflurane.


The risk or severity of adverse effects can be increased when quinidine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with tolazoline.


The risk or severity of adverse effects can be increased when Conivaptan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when thalidomide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with minoxidil.